Celestial Biolabs Ltd Financials
Company Logo

Celestial Biolabs Ltd Financial Statement

Celestial Biolabs Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Dec 2023
Revenue0.04
Operating Expense0.07
Net Profit-0.03
Net Profit Margin-75.00
Earning Per Share-0.02
EBIDTA-0.02
Effective Tax RateTBA

Celestial Biolabs Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2023
Total Revenue Annual0.17
Operating Expenses Annual0.71
Operating Profit Annual-0.54
Interest Annual0.00
Depreciation0.03
Net Profit Annual-0.57
Tax AnnualTBA

Celestial Biolabs Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2023
Cash Flow at the BeginningTBA
Cash Flow from Operations-0.35
Cash Flow from Investing-0.01
Cash Flow from Financing0.37
Cash Flow at the End0.02

Celestial Biolabs Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2023
PBDIT Margin (%)-317.65
PBIT Margin (%)-335.29
PBT Margin (%)-335.29
Net PROFIT Margin (%)-335.29
Return On Networth / Equity (%)TBA
Return On Networth /Employed (%)TBA
Return On Assets (%)-3.35
Total Debt / Equity (X)3.83
Asset Turnover Ratio (%)0.01

Celestial Biolabs Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2023
Fixed Assets Annual0.08
Total Current Assets Annual4.14
Non Current Assets Annual12.90
Total Shareholders Funds Annual2.78
Total Assets Annual17.03

Celestial Biolabs Ltd Earning Calls

EPS (INR)

Expected

0.00

Reported

-0.02

Surprise

0.00%

Sep 2023

EPS beaten by 0.00%

Jun 2023

EPS beaten by 0.00%

Mar 2023

EPS beaten by 0.00%

Get Your FAQs Right

As of Jan 15, 2025, Celestial Biolabs Ltd has a market capitalization of - Cr. Value Research classifies it as a Micro-Cap company.
No, Celestial Biolabs Ltd is not debt-free with a debt-to-equity ratio of 4.29.
In FY 2024 , Celestial Biolabs Ltd recorded a total revenue of approximately 0.17 Cr marking a significant milestone in the company's financial performance.
Celestial Biolabs Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately NaN% and Infinity% annually, respectively..
Celestial Biolabs Ltd's current PE ratio is undefined.
Celestial Biolabs Ltd's ROCE averaged -2.6% from the FY ending March 2021 to 2023, with a median of -2.7%. It peaked at -1.1% in March 2021, reflecting strong capital efficiency over the period..
Celestial Biolabs Ltd's latest EBIT is Rs. -0.57 Cr, surpassing the average EBIT of Rs. -0.38 Cr over the 5 years..

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions